Insulin

|

33

Lilly Expands Affordability With Lower-Priced Versions of Popular Insulin

Eli Lilly today announced plans to add two more cost-saving options to its suite of solutions for people who use Lilly insulin. The company plans to …

|

Researchers Find Way to Distinguish Type 1 Diabetes from Type 1.5 Diabetes

A multi-center team of researchers led by Children’s Hospital of Philadelphia (CHOP) has discovered a genetic signature that could help …

| |

Small UBC Study Finds Ketone Drink May Help Control Blood Sugar

With more people with diabetes and pre-diabetes looking for strategies to help control blood sugar, new research from the University of British …

|

Maker of Lantus Insulin Announces It Will Exit Diabetes Research

French drugmaker, Sanofi SA announced on Tuesday that will stop pouring in money to research diabetes and cardiovascular (DCV). The news came from …

|

New Doors Open for People with Diabetes with Amended FAA Protocol

The Federal Aviation Administration (FAA) announced new protocols for pilots with insulin-treated diabetes, which will allow them to fly commercial …

| |

FAA May Allow Pilots with Insulin-Treated Diabetes to Fly Commercial Airplanes

CNN reported last week that the Federal Aviation Administration (FAA) may allow pilots with insulin-treated diabetes to fly commercial airplanes. If …

| |

Novo Nordisk Launches New Insulin Affordability Options in the U.S.

Novo Nordisk announced it will expand the company’s insulin affordability offering in the U.S. beginning on January 2, 2020. The news comes at …

|

FDA Approves Myxredlin, The First and Only Ready-To-Use Insulin for IV Infusion

Baxter International Inc. today announced the U.S. Food and Drug Administration (FDA) has approved Myxredlin Myxredlin (pronounced mix-RED-lin) is …

|

Dance Biopharm Announces Encouraging Data from Phase 2 Clinical Trial of Inhaled Insulin

Dance Biopharm recently presented phase 2 trial results for its inhaled preservative-free human insulin, Dance 501, for the treatment of Type 2 …

One Drop Launches Blood Glucose “Forecasts” for People with Type 2 Diabetes on Insulin

One Drop announced the expansion of their AI-powered Predictive Insights to include 8-hour blood glucose forecasts for One Drop, Mobile iOS users …

|